Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.
Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Eur J Cardiothorac Surg. 2022 Jun 15;62(1). doi: 10.1093/ejcts/ezac345.
We used individual patient data from 4 of the largest contemporary coronary bypass surgery trials to evaluate differences in long-term outcomes when radial artery (RA), right internal thoracic artery (RITA) or saphenous vein graft (SVG) are used to complement the left internal thoracic artery-to-left anterior descending graft.
Primary outcome was all-cause mortality. Secondary outcome was a composite of major adverse cardiac and cerebrovascular events (all-cause mortality, myocardial infarction and stroke). Propensity score matching and Cox regression were used to reduce the effect of treatment selection bias and confounders.
A total of 10 256 patients (1510 RITA; 1385 RA; 7361 SVG) were included. The matched population consisted of 1776 propensity score-matched triplets. The mean follow-up was 7.9 ± 0.1, 7.8 ± 0.1 and 7.8 ± 0.1 years in the RITA, RA and SVG cohorts respectively. All-cause mortality was significantly lower in the RA versus the SVG [hazard ratio (HR) 0.62, 95% confidence interval (CI): 0.51-0.76, P = 0.003] and the RITA group (HR 0.59, 95% CI 0.48-0.71, P = 0.001). Major adverse cardiac and cerebrovascular event rate was also lower in the RA group versus the SVG (HR 0.78, 95% CI 0.67-0.90, P = 0.04) and the RITA group (HR 0.75, 95% CI 0.65-0.86, P = 0.02). Results were consistent in the Cox-adjusted analysis and solid to hidden confounders.
In this pooled analysis of 4 large coronary bypass surgery trials, the use of the RA was associated with better clinical outcomes when compared to SVG and RITA.
我们利用 4 项最大的当代冠状动脉旁路移植术试验的个体患者数据,评估当使用桡动脉(RA)、右内乳动脉(RITA)或隐静脉移植物(SVG)来补充左内乳动脉至前降支移植物时,长期结局的差异。
主要结局为全因死亡率。次要结局为主要不良心脏和脑血管事件的复合结局(全因死亡率、心肌梗死和卒中等)。采用倾向评分匹配和 Cox 回归来降低治疗选择偏倚和混杂因素的影响。
共纳入 10256 例患者(1510 例 RITA;1385 例 RA;7361 例 SVG)。匹配的队列包括 1776 例倾向评分匹配的三联体。RITA、RA 和 SVG 组的平均随访时间分别为 7.9±0.1、7.8±0.1 和 7.8±0.1 年。RA 组与 SVG 组(风险比 [HR] 0.62,95%置信区间 [CI]:0.51-0.76,P=0.003)和 RITA 组(HR 0.59,95% CI 0.48-0.71,P=0.001)的全因死亡率显著降低。RA 组的主要不良心脏和脑血管事件发生率也低于 SVG 组(HR 0.78,95% CI 0.67-0.90,P=0.04)和 RITA 组(HR 0.75,95% CI 0.65-0.86,P=0.02)。在 Cox 调整分析和对潜在混杂因素的稳健性检验中,结果一致。
在这 4 项大型冠状动脉旁路移植术试验的汇总分析中,与 SVG 和 RITA 相比,RA 的使用与更好的临床结局相关。